DCF — BAYFRONT HEALTH ST. PETERSBURG
Enterprise Value: $-562.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-562.5M
Enterprise Value
$-175.8M
PV of Cash Flows
$-386.7M
PV of Terminal Value
$-622.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $287.4M | $-36.2M | -13.0% | $-48.4M | $-44.0M |
| Year 2 | $296.0M | $-34.4M | -12.0% | $-46.9M | $-38.7M |
| Year 3 | $304.9M | $-32.3M | -11.0% | $-45.2M | $-34.0M |
| Year 4 | $314.0M | $-31.7M | -10.0% | $-45.0M | $-30.8M |
| Year 5 | $323.5M | $-31.9M | -10.0% | $-45.6M | $-28.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-562.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$279.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13106380172894513
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5